Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma

Cancer Treat Rep. 1987 Apr;71(4):429-30.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carmustine / administration & dosage
  • Clinical Trials as Topic
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Melanoma / drug therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Thioguanine / administration & dosage

Substances

  • Thioguanine
  • Carmustine